Biotech Values

[NP1986]

I very much take your point on the balance issue (it is a fairly small trial), but I nevertheless think the OS results will drive the stock. Maybe they shouldn't, but they will.

I wouldn't be surprised if the share price continues to increase due to over-exuberance. I just hope the longs realize that the phase II results themselves are unlikely to lead to approval, despite what some of the PPHM execs have suggested. They will probably need a phase III trial to confirm the OS results, and I doubt they have enough cash for that.